HIGHLIGHTS
- who: Takahiro Mori from the Department of General Science, Graduate School of Medicine, Chiba University, ‑8‑, Inohana, Chuo‑ku, Chiba, Chiba, ‑8670, Japan have published the Article: Cost-effectiveness of zoledronic acid compared with sequential denosumab/alendronate for older osteoporotic women in Japan, in the Journal: (JOURNAL)
- how: Summary Among hypothetical cohorts of older osteoporotic women without prior fragility fracture in Japan the authors evaluated the cost-effectiveness of two treatment strategies using a simulation model. As this small single-center study seemed to lack generalizability and the authors also could not find a counterpart . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.